FDA NDC Directory · JSON-LD · Markdown
NDC 0641-6251 · HUMAN PRESCRIPTION DRUG · INJECTION
| Labeler / Manufacturer | Hikma Pharmaceuticals USA Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA213561 |
| Dosage form / route | INJECTION · ENDOTRACHEAL INTRAMEDULLARY INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
| Active ingredients | ATROPINE SULFATE (.4 mg/mL) |
| Marketing started | 20211201 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).